VEGFA and cardiac hypertrophy: Moreover, systemic administration of VEGF‐C156S effectively attenuated TAC stress‐induced cardiac edema and hypertrophy, thereby improving cardiac dysfunction as detected by echocardiography and invasive LV PV analysis.